Commentary Population screening in the NHS: a systematic pathway from evidence to policy formulation
|
|
- Bryan Gilbert
- 5 years ago
- Views:
Transcription
1 Journal of Public Health Medicine Vol. 20, No. 1, pp Printed in Great Britain Commentary Population screening in the NHS: a systematic pathway from evidence to policy formulation Robert Sherriff, Lesley Best and Paul Roderick Summary In 1994 the Chief Medical Officer of England set out a framework for the evaluation and implementation of national screening programmes in the National Health Service (NHS). The framework highlighted the importance of the link between research evidence and the formulation of national policy. It also stressed the necessity for monitoring, evaluation and quality control as integral components for all new screening programmes. There is now an established link between the Health Technology Assessment programme of the NHS Research and Development Directorate and the NHS's new policy advisory group, the National Screening Committee. The objective of this systematic approach is to ensure that screening programmes are not introduced into the NHS unless there is robust evidence that benefit outweighs harm. The Population Screening Panel, an advisory panel of the NHS Health Technology Assessment programme, has the responsibility for determining priorities in research on proposed or existing population screening programmes. The National Screening Committee has a remit to consider this research evidence and to advise government ministers and the NHS on the appropriateness of the implementation, development and modification of national screening programmes. The example of prostatic cancer screening is presented as an illustration of how the NHS is developing a systematic approach to the implementation of screening policy based upon the strategic commissioning of research evidence. Keywords: screening, Health Technology National Health Service, policy Introduction Assessment, In 1994 the Chief Medical Officer of England, Sir Kenneth Caiman, set out a framework for the evaluation and implementation of national screening programmes in the National Health Service (NHS). 1 The framework recognized that screening is a complex intervention which incorporates not only the scientific issues of effectiveness, but also ethical dimensions and the issues of organizational and quality assurance infrastructure. In particular, it highlighted the importance of the link between research evidence and the formulation of national screening policy. The framework also stressed the necessity to ensure that monitoring, evaluation and quality control were integral components of the implementation plan for all new screening programmes. The objective of this systematic approach is threefold: (1) to ensure that screening programmes are not introduced into the NHS unless there is robust evidence that benefit outweighs harm; (2) to ensure that new programmes meet the recognized criteria for population screening programmes; 2 (3) to ensure that programmes are implemented with built-in management plans, quality assurance and explicit quality standards. It is hoped that this third point will prevent any future screening programmes from being introduced in an ad hoc fashion with the resulting variation in local practice, standards and organization. The intervening years have seen the implementation of this framework to the extent that there is now an established link between the Health Technology Assessment programme of the NHS Research and Development programme and the new policy advisory group, the National Screening Committee. This paper will describe the collaborative process and will use the example of prostatic cancer screening as an illustration of how the NHS is developing a systematic approach to the implementation of screening policy based upon the strategic commissioning of research evidence. Population screening and the Health Technology Assessment programme The Health Technology Assessment (HTA) programme, established in 1993, is the largest single programme of work within the NHS Research and Development strategy. The National Screening Committee Secretariat, NHS Executive Anglia and Oxford, 6-12 Capital Drive, Linford Wood, Milton Keynes MK14 6QP. Robert SherrilT, Specialist Registrar in Public Health Medicine National Coordinating Centre for Health Technology Assessment, Wessex Institute for Health Research and Development, University of Southampton, Biomedical Sciences Building, Bassett Crescent East, Southampton SO 16 7PX. Ledey Best, Research Fellow Paul Roderick, Senior Lecturer in Public Health Medicine Address correspondence to Lesley Best Oxford University Press 1998
2 POPULATION SCREENING IN THE NHS 59 Central Research & Development Committee (CRDC) Standing Group on Health Technology (SGHT) Commissioning Group on Health Technology (CGHT) Advisory Panels Population Screening Acute Sector Primary & Community Care programme is a systematic, needs-led approach which aims to commission research in those areas of greatest importance to the NHS. Questions on the effectiveness and cost-effectiveness of health technologies are the primary focus of this programme, which commissions both primary and secondary research. 3 The structure of the HTA programme is illustrated in Fig. 1. The Standing Group on Health Technology Assessment advises on national priorities for research and is aided by six expert advisory panels. The Population Screening Panel has the responsibility for determining priorities of research on proposed or existing population screening services, the minority of which are currently organized as formal 'programmes'. The panel has a wide remit which includes both screening of the general population and high-risk sub-groups. Recommendations from the six advisory panels are forwarded to the Standing Group, which selects approximately 50 research areas per year for funding. Table 1 Sources in 1997 identification process Diagnostics Pharmaceuticals Methodologies & Imaging Scientific Secretariat Support Figure 1 Structures of the HTA programme. 3 A 'bottom-up' approach is adopted for the identification of potential HTA research questions eliciting the concerns of purchasers, providers and users of health care services, as well as the academic community and professional bodies (Table 1 lists the consultation sources for the 1997 identification round). Research questions may relate to specific screening programmes (thereby considering the performance of screening tests, effectiveness of early interventions, acceptability to participants, compliance, facilities for implementation, and quality assurance mechanisms) or to generic issues affecting all screening activities (e.g. factors affecting uptake, impact of false-negative results). Research is considered on both new (e.g. fragile X) and existing screening programmes (e.g. child health surveillance). The Population Screening Panel has an important role in that it is required to judge the merits of each topic in terms of the importance to the NHS. Explicit criteria are laid out to aid this Widespread mailing including Royal Colleges, academic departments, hospitals, chanties, and guideline groups Survey of Regional Research and Development Directors, and Research and Development Support Units National Screening Committee, Department of Health expert advisory groups Faculty of Public Health Medicine Screening Committee Standing Medical Advisory Committee Focus groups of general practitioners and purchasers Scanning the research recommendations from completed HTA pnmary research and systematic reviews; scanning of recent Cochrane reviews Regular scanning of relevant journals by panel researchers, e.g. Journal of Medical Screening Advertisement in Bandolier and Health Service Journalfor suggested research topics
3 60 JOURNAL OF PUBLIC HEALTH MEDICINE 1. (NCCHTA) Identifying the problemsforthenhs National Screening Committee 6. (NHS) Using research results and evaluating change Population Screening Panel 2. (NCCHTA) Translating problems into research questions 5. Research results decision-making, including consideration of the burden of disease, current levels of uncertainty, importance of early assessment, pace of diffusion, and the value for money of the research. The panel is also guided by the Wilson and Jungner criteria for the assessment of screening programmes. 2 The Population Screening panel has 12 expert members representing a wide range of screening expertise including antenatal and neonatal screening, child health surveillance, cancer and cardiovascular disease, women's health, the psychosocial and economic impact of health care interventions, and genetic screening. Current research given priority by the Population Screening panel (and commissioned by the HTA programme) includes both new and existing programmes and is largely in the form of systematic reviews, e.g. screening for cystic fibrosis, screening for stroke through detection and management of hypertension, screening for fragile X, preschool vision screening, and screening for Down's syndrome. Some major randomized controlled trials given priority are being taken forward by the Medical Research Council, namely screening for colorectal cancer by flexible sigmoidoscopy and screening for abdominal aortic aneurysm in men aged years. The entire HTA programme is supported by the National Coordinating Centre for HTA (NCCHTA), based at the Wessex Institute for Health Research and Development, University of Southampton, in collaboration with partners at the Centre for Health Economics and Department of Health Sciences and Clinical Evaluation, at the University of York. The NCCHTA supports the six HTA panels and the Standing Group by co-ordinating consultation, compiling key information to aid priority setting, managing the commissioning process, monitoring current research and publishing completed work. The cyclical nature of the research process within the HTA programme is illustrated in Fig. 2. Once topics are given priority by the Standing Group, the majority are advertised 4. Funding projects within priority areas Figure 2 Stages of the HTA research cycle. 3.(PSP,SGHT) Prioritising research topics nationally for interested parties to work up proposals. Institutional curriculum vitaes and outline proposals are shortlisted by the Commissioning Group, whoseremitis to advise on the quality and value of work, and relevance to the HTA priority. Proposals are refereed by external experts before selection and commissioning. Current research is monitored through site visits and the submission of progress reports, to ensure the quality and timeliness of work. Completed research is publicly available, after peer review and revision as necessary. Within the HTA programme, the area of population screening is unique in that the knowledge outputs of the programme are automatically considered for implementation, following the establishment of the National Screening Committee. This important link between high-quality research and controlled implementation will be pivotal in promoting evidence-based population screening policies. The National Screening Committee The National Screening Committee, which first met in July 1996, has a remit to advise Department of Health ministers, the Government's Chief Medical Officer (CMO) and the NHS Executive on the timeliness and appropriateness of the implementation, development, review and modification of national screening programmes. The basis for this advice is evidence on clinical and cost-effectiveness, population need, medical ethics and clinical outcomes. Potential screening programmes exist in every specialty and sub-specialty of clinical practice, and for this reason it would not have been possible to have every group represented on the National Screening Committee. Members were therefore selected to form a body which would be able to consider screening programmes in their broadest perspective. The Committee, chaired by the Chief Medical Officer (CMO) of England, has a membership including the CMOs of Northern
4 POPULATION SCREENING IN THE NHS 61 Ireland, Scotland and Wales, Directors of Public Health, the chairman of the Population Screening Panel, a general practitioner, a journalist, a consumer representative and the NHS Finance Director. The National Screening Committee will consider evidence on both new and existing screening programmes. This evidence, usually in the form of randomized controlled trials or systematic reviews, may originate from the Health Technology Assessment programme or elsewhere. If the National Screening Committee decides that further information is required, this task will be co-ordinated by specialist subgroups which will have the authority to co-opt expert members from outside of the main committee. Currently, specialist subgroups exist for antenatal screening and the ethics of screening. A key task of these sub-groups will be to consider how monitoring, evaluation and quality assurance would be managed for each screening programme. The National Screening Committee will expect this information to be included as an integral part of the implementation plan for any new screening programme. The scientific secretariat for the National Screening Committee is located at the NHS Executive Anglia and Oxford Regional Office in Milton Keynes. All enquiries regarding screening programmes and the future work programme of the National Screening Committee may be addressed to this office (National Screening Committee Secretariat, NHS Executive Anglia and Oxford, 6-12 Capital Drive, Linford Wood, Milton Keynes MK14 6QP). The National Screening Committee secretariat is developing an inventory of current and potential screening programmes, which is being used to help determine priorities in the future work programme of the Committee. It is anticipated that during the next three years the National Screening Committee will consider the majority of potential screening programmes which have been proposed for national implementation. This work will eventually lead to the development of three categories of screening programmes: (1) screening programmes which should be offered to the public; (2) screening programmes which should not be offered to the public; (3) screening programmes which should only be offered to the public as part of a formal research trial. An example of the work so far: screening for prostate cancer The diagnosis and management of early prostate cancer arose from both the Population Screening and Diagnostics and Imaging HTA panels in An important part of this topic was the cost-effectiveness of screening for prostate cancer (including the use of the prostatic-specific-antigen (PSA) test). There is currently no organized national screening programme for prostate cancer. An urgent assessment was required as ad hoc PSA testing was known to be taking place. Table 2 Key findings from systematic reviews on prostate cancer screening 6 Routine testing of men to detect prostate cancer should be discouraged, irrespective of family history Purchasers should not fund screening services for prostate cancer Evidence from randomized controlled trials of prostate cancer screening using PSA (or similar tests) and treatment are needed before consideration is given to funding prostate cancer screening Patients enquiring about prostate screening should be clearly informed about the current state of evidence on the benefits and harms of screening and treatment In early 1994, the HTA Commissioning Group invited full proposals from a number ofresearchcentres, of which two were selected to undertake systematic reviews. This selection followed extensive discussions on the scientific merit of each proposal, relevance to the priority area, and peer review by external experts. The systematic reviews were undertaken by research teams at the Department of Social Medicine, University of Bristol, 4 and the Cancer Screening Evaluation Unit, Institute of Cancer Research. 5 After completion, each report was peer-reviewed by three referees, and final reports were issued in July 1996 and November 1996, respectively. Key findings from systematic reviews of prostate cancer screening are summarized in Table 2. Further research on prostatic cancer has been commissioned in the 1996 round of HTA priorities, the key question being the effectiveness of treatments in early (screen-detected) prostatic cancer. A press launch organized by the NHS Centre for Reviews and Dissemination, University of York, was held in February 1997, to publicize these systematic reviews (available from National Coordinating Centre for HTA, The Wessex Institute for Health Research and Development, University of Southampton, Biomedical Sciences Building, Bassett Crescent East, Southampton SO 16 7PX; and toreleasesummary reports aimed at patients, clinicians and purchasers. 6 ' 7 Subsequently, the reports received coverage in The Lancet, 6 where issues were raised about the importance of patient views and the merits of consensus conferences in the formulation of health policy. The HTA reports (and programme) received both praise and criticism in the letters that followed. 9 ' 10 The two systematic reviews were considered by the National Screening Committee in early In particular, the Committee focused on the criterion that there must be evidence that benefit from screening outweighs harm. In light of the lack of evidence to support this, the National Screening Committee concluded that population screening for prostatic cancer should not be offered to the public. This advice, having been accepted by ministers and the NHS Executive, was subsequently disseminated to the wider NHS in the form of an Executive Letter."
5 62 JOURNAL OF PUBLIC HEALTH MEDICINE Conclusion This paper has described a systematic and strategic approach to the commissioning of research and the formulation of an evidence-based national screening policy. It is anticipated that this process will continue to form a useful and robust mechanism for developing NHS screening policy into the twenty-first century. Acknowledgements We are grateful to Dr Ruairidh Milne and Dr Muir Gray for their helpful comments. References 1 Caiman K. Developing screening in the NHS. J Med Screen 1994; 1: Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva: WHO, NHS Executive. Report of the NHS Health Technology Assessment programme. London: Department of Health, Selley S, Donovan J, Faulker A, Coast J, Gillat D. Diagnosis, management and screening of early localised prostate cancer: a systematic review. Health Technol Assessment 1997; 1(2). 5 Chamberlain J, Melia J, Moss S, Brown J. The diagnosis, management, treatment and costs of prostate cancer in England and Wales. Health Technol Assessment 1997; 1(3). 6 NHS Centre for Reviews and Dissemination. Screening for prostate cancer. Effectiveness matters. York: University of York, NHS Centre for Reviews and Disseminatioa Information for men considering or asking for PSA tests. Effectiveness matters. York: University of York, Anonymous. The prostate question, unanswered still (Editorial). Lancet 1997; 349: Swales J, Winyard G. Screening for prostate cancer (letters). Lancet 1997; 349: Woolf S. Screening for prostate cancer (letters). Lancet 1997; 349: NHS Executive. Population screening for prostate cancer. EL (97)12. Leeds: Department of Health, Accepted on 16 September 1997
We are currently recruiting new members to advisory groups for the following research programmes:
Information for applicants to join NIHR as an advisory group member: HTA Programme Topic Identification, Development and Evaluation (TIDE) panel Chairs 1. Background information The goal of the National
More informationPublic Health Observatories: An introduction to the London Health Observatory in England and recent developments in Alberta. Learning objectives
Public Health Observatories: An introduction to the London Health Observatory in England and recent developments in Alberta Justine Fitzpatrick 19 th February 2008- Public Health WORKS Speaker Series Learning
More informationAlcohol Research UK Research Strategy
Alcohol Research UK Research Strategy 2015-18 Supporting research to reduce alcohol-related harm www.alcoholresearchuk.org Alcohol Research UK Research Strategy 2015-18 Foreword Professor Alan-Maryon Davies
More informationRoyal College of Radiologists (RCR) Referral guidelines. Final Accreditation Report. Guidance producer: Guidance product: Date: 29 June 2010
Guidance producer: Royal College of Radiologists (RCR) Guidance product: Referral guidelines Date: 29 June 2010 Final Accreditation Report Contents Introduction... 3 Accreditation recommendation... 3 Implementation...
More informationBritish Association of Stroke Physicians Strategy 2017 to 2020
British Association of Stroke Physicians Strategy 2017 to 2020 1 P age Contents Introduction 3 1. Developing and influencing local and national policy for stroke 5 2. Providing expert advice on all aspects
More informationabcdefghijklmnopqrstu
CMO and Public Health Directorate Health Improvement Strategy Division Dear Colleague Scottish Abdominal Aortic Aneurysm Screening Programme This CEL outlines the plan for the implementation of the AAA
More informationHEALTH AND SPORT COMMITTEE AGENDA. 14th Meeting, 2018 (Session 5) Tuesday 1 May 2018
HS/S5/18/14/A HEALTH AND SPORT COMMITTEE AGENDA 14th Meeting, 2018 (Session 5) Tuesday 1 May 2018 The Committee will meet at 10.00 am in the James Clerk Maxwell Room (CR4). 1. Scottish Health Council Review:
More informationDementia Priority Setting Partnership. PROTOCOL March 2012
Dementia Priority Setting Partnership PROTOCOL March 2012 Purpose The purpose of this protocol is to set out the aims, objectives and commitments of the Dementia Priority Setting Partnership (PSP) and
More informationAPPENDIX 2. Appendix 2 MoU
APPENDIX 2 THIS APPENDIX CONTAINS BOTH THE TEXT OF THE CURRENT MEMORANDUM OF UNDERSTANDING BETWEEN JCSTD, THE GDC AND COPDEND ABOUT THEIR JOINT WORKING ARRANGEMENTS AND THE WORKING NOTES DRAFTED BY PROF
More informationProstate Cancer Priority Setting Partnership. PROTOCOL June 2009
Prostate Cancer Priority Setting Partnership PROTOCOL June 2009 Purpose The purpose of this protocol is to set out the aims, objectives and commitments of the Prostate Cancer Priority Setting Partnership
More informationThe NHS Cancer Plan: A Progress Report
DEPARTMENT OF HEALTH The NHS Cancer Plan: A Progress Report LONDON: The Stationery Office 9.25 Ordered by the House of Commons to be printed on 7 March 2005 REPORT BY THE COMPTROLLER AND AUDITOR GENERAL
More informationNational. First Report of the National. Screening Committee
National Screening Committee First Report of the National Screening Committee Health Departments of the United Kingdom April 1998 This Department of Health report has been produced in partnership with
More informationAccess to newly licensed medicines. Scottish Medicines Consortium
Access to newly licensed medicines Scottish Medicines Consortium Modifiers The Committee has previously been provided with information about why the SMC uses modifiers in its appraisal process and also
More informationWELSH GOVERNMENT RESPONSE TO RECOMMENDATIONS FROM THE HEALTH & SOCIAL CARE COMMITTEE: INQUIRY INTO NEW PSYCHOACTIVE SUBSTANCES
WELSH GOVERNMENT RESPONSE TO RECOMMENDATIONS FROM THE HEALTH & SOCIAL CARE COMMITTEE: INQUIRY INTO NEW PSYCHOACTIVE SUBSTANCES Recommendation 1 The Committee recommends that the Minister for Health and
More informationThe National perspective Public Health England s vision, mission and priorities
The National perspective Public Health England s vision, mission and priorities Dr Ann Hoskins Director Children, Young People and Families Public Health England May 2013 Mission Public Health England
More informationWales Abdominal Aortic Aneurysm Screening Programme (WAAASP) Policies
Wales Abdominal Aortic Aneurysm Screening Programme (WAAASP) Policies Author: Llywela Wilson, Programme Lead Policy lead: Llywela Wilson, Programme Lead Executive lead: Dr Rosemary Fox, Acting Director
More information600 guests , TV broadcast. Collaboration opportunities Contact: David Bell NEWS stories TEAMS
200,000+ BRANDED EMAILS SENT 17 patient representatives 1 TV broadcast 1,276 tweets on awards night 43 EXPERT JUDGES 21 regional NEWS stories 300+ ENTRIES 600 guests 2018 Collaboration opportunities Contact:
More informationDUMFRIES AND GALLOWAY ALCOHOL AND DRUG PARTNERSHIP; PRIORITY ACTIONS AND
DUMFRIES AND GALLOWAY ALCOHOL AND DRUG PARTNERSHIP; PRIORITY ACTIONS 2013-14 AND 2014-15 RECOMMENDATION/WORKPLAN CURRENT POSITION IN D & G PLAN 1. Annual Report 1.1 Develop robust reporting mechanisms
More informationThe Ayrshire Hospice
Strategy 2010-2015 Welcome... The Ayrshire Hospice : Strategy 2010-2015 Index 05 06 08 09 10 12 15 17 19 Foreword Our vision and purpose Our guiding principles Our achievements 1989-2010 Our priorities
More informationRoyal College of Physicians (RCP) National Clinical Guidelines for Stroke. Final Accreditation Report. Guidance producer: Guidance product:
Guidance producer: Royal College of Physicians (RCP) Guidance product: National Clinical Guidelines for Stroke Date: 29 June 2010 Final Accreditation Report Contents Contents... 2 Introduction... 3 Implementation...
More informationCommittee of Senior Representatives Tenth Meeting Oslo, Norway 11 December 2006
Committee of Senior Representatives Tenth Meeting Oslo, Norway 11 December 2006 Reference CSR 10/7.1/1 Title Proposed Terms of Reference for the EG on HIV/AIDS Submitted by Secretariat Summary / Note As
More information2.2 The primary roles and responsibilities of the Committee are to:
Edinburgh Child Protection Constitution 1. Introduction 1.1 This document sets out the governance arrangements established to promote the delivery of integrated, high quality child protection services
More informationCosting report: Lipid modification Implementing the NICE guideline on lipid modification (CG181)
Putting NICE guidance into practice Costing report: Lipid modification Implementing the NICE guideline on lipid modification (CG181) Published: July 2014 This costing report accompanies Lipid modification:
More information1. Purpose of the Pessary PSP and background
Pessary Priority Setting Partnership PROTOCOL May 2016 1. Purpose of the Pessary PSP and background The purpose of this protocol is to set out the aims, objectives and commitments of the Pessary Priority
More informationPROPOSED WORK PROGRAMME FOR THE CLEARING-HOUSE MECHANISM IN SUPPORT OF THE STRATEGIC PLAN FOR BIODIVERSITY Note by the Executive Secretary
CBD Distr. GENERAL UNEP/CBD/COP/11/31 30 July 2012 ORIGINAL: ENGLISH CONFERENCE OF THE PARTIES TO THE CONVENTION ON BIOLOGICAL DIVERSITY Eleventh meeting Hyderabad, India, 8 19 October 2012 Item 3.2 of
More informationLocal Healthwatch Quality Statements. February 2016
Local Healthwatch Quality Statements February 2016 Local Healthwatch Quality Statements Contents 1 About the Quality Statements... 3 1.1 Strategic context and relationships... 5 1.2 Community voice and
More informationAll Party Parliamentary Group for Children inquiry into children s social care invitation to submit written evidence
All Party Parliamentary Group for Children c/o NCB (Policy) 8 Wakley Street London EC1V 7QE Dear Directors of Children s Services, All Party Parliamentary Group for Children inquiry into children s social
More informationHTA. Smoking-cessation treatments. Executive summary
The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation Smoking-cessation treatments NF Woolacott
More informationDiabetes Action Now. Consultation on a new WHO-IDF programme
World Health Organization Consultation on a new WHO-IDF programme A call for your views This document announces a new World Health Organization International Diabetes Federation (WHO-IDF) programme,. The
More informationStrategy for Personal and Public Involvement (PPI)
Strategy for Personal and Public Involvement (PPI) in Health and Social Care research HSC Research & Development Division Foreword I am delighted to present the second edition of the HSC R&D Division s
More informationAnnual Report of Estyn s Audit and Risk Assurance Committee
Annual Report of Estyn s Audit and Risk Assurance Committee 1 Purpose 1.1 This report summarises the main work of the Estyn Audit and Risk Assurance Committee during the period 1 st April 2013 31 st March
More informationCancer Control Council Evaluation and Monitoring Framework
Cancer Control Council Evaluation and Monitoring Framework Table of contents 1. Purpose...1 2. Background...1 3. Clarification of key tasks...2 4. International evaluation and monitoring frameworks...3
More informationA Framework for Optimal Cancer Care Pathways in Practice
A to Guide Care Cancer Care A for Care in Practice SUPPORTING CONTINUOUS IMPROVEMENT IN CANCER CARE Developed by the National Cancer Expert Reference Group to support the early adoption of the A to Guide
More informationRE: ADVISORY PANEL ON SUBSTANCE MISUSE - REVIEW OF THE POLICY INTERVENTIONS NEEDED TO TACKLE SUBSTANCE MISUSE IN AN AGEING POPULATION
Y Panel Cynghori ar Gamddefnyddio Sylweddau Advisory Panel on Substance Misuse To: See Distribution List Eich Cyf/Your Ref: Ein Cyf/Our Ref: 30 th January 2015 Dear Colleague, RE: ADVISORY PANEL ON SUBSTANCE
More informationCANDIDATE PACK. Trustee
CANDIDATE PACK Trustee Candidate Pack 2014 Background Information Introduction The Motor Neurone Disease (MND) Association is the only national charity in England, Wales and Northern Ireland that funds
More informationMS Priority Setting Partnership. PROTOCOL August 2012
MS Priority Setting Partnership PROTOCOL August 2012 Purpose The purpose of this protocol is to set out the aims, objectives and commitments of the MS Priority Setting Partnership (PSP) and the basic roles
More informationMRC Network of Hubs for Trials Methodology Research Gordon Murray, University of Edinburgh
Edinburgh All All Ireland Ireland North West Midlands MRC-CTSU - CTSU MRC MRC- - BSU ConDuCT MRC- - CTU MRC Network of Hubs for Trials Methodology Research Gordon Murray, University of Edinburgh www.methodologyhubs.mrc.ac.uk
More informationCONSTITUTION SOUTHAMPTON CHILDREN & YOUNG PEOPLE S TRUST PARTNERSHIP
CONSTITUTION SOUTHAMPTON CHILDREN & YOUNG PEOPLE S TRUST PARTNERSHIP 1. AIMS To unify and co-ordinate services for children, young people and families in line with the Children Act 2004 To oversee the
More informationAlcohol and Drug Commissioning Framework for Northern Ireland Consultation Questionnaire.
Alcohol and Drug Commissioning Framework for Northern Ireland 2013-16 Consultation Questionnaire. This questionnaire has been designed to help stakeholders respond to the above framework. Written responses
More informationThe role of cancer networks in the new NHS
The role of cancer networks in the new NHS October 2012 UK Office, 89 Albert Embankment, London SE1 7UQ Questions about cancer? Call the Macmillan Support Line free on 0808 808 00 00 or visit macmillan.org.uk
More informationTHE MULTI-SECTORAL APPROACH TO AIDS CONTROL IN UGANDA EXECUTIVE SUMMARY
THE MULTI-SECTORAL APPROACH TO AIDS CONTROL IN UGANDA EXECUTIVE SUMMARY Uganda AIDS Commission February 1993 EXECUTIVE SUMMARY 1. Introduction Background Information to AIDS in Uganda 1. AIDS was first
More informationEvaluation of the Health and Social Care Professionals Programme Interim report. Prostate Cancer UK
Evaluation of the Health and Social Care Professionals Programme Interim report Prostate Cancer UK July 2014 Contents Executive summary... 2 Summary of the research... 2 Main findings... 2 Lessons learned...
More informationAnnotations to the provisional agenda
Technology Executive Committee 29 August 2017 Fifteenth meeting Bonn, Germany, 12 15 September 2017 Annotations to the provisional agenda 1. Opening of the meeting 1. The Chair of the Technology Executive
More informationEngaging People Strategy
Engaging People Strategy 2014-2020 Author: Rosemary Hampson, Public Partnership Co-ordinator Executive Lead Officer: Richard Norris, Director, Scottish Health Council Last updated: September 2014 Status:
More informationPaediatric and Adolescent HIV Research Grant Programme
Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Paediatric and Adolescent HIV Research Grant Programme Call for Letter of Intent Table of Contents I. GRANT INFORMATION... 2
More informationCommonwealth Secretariat
Commonwealth Secretariat Commonwealth Health Ministers Meeting Geneva, Switzerland, 15 May 2011 Theme: Non-Communicable Diseases A Priority for the Commonwealth Agenda Item V HMM(G)(11)4 PROGRESS REPORT:
More informationCANCER IN SCOTLAND: ACTION FOR CHANGE The structure, functions and working relationships of Regional Cancer Advisory Groups
CANCER IN SCOTLAND: ACTION FOR CHANGE The structure, functions and working relationships of Regional Cancer Advisory Groups Introduction/Background 1. Our National Health: A Plan for action, a plan for
More information2. The role of CCG lay members and non-executive directors
CCG Lay Members, Non-Executive Directors and STP Governance and Engagement 1. Introduction Report from network events organised by NHS England and NHS Clinical Commissioners in February 2017 This briefing
More informationScreening. Dr Helen Raison Consultant, Public Health Royal Borough of Kingston
Screening Dr Helen Raison Consultant, Public Health Royal Borough of Kingston What is screening? Screening is a process of identifying apparently healthy people who may be at increased risk of a disease
More informationThe audit is managed by the Royal College of Psychiatrists in partnership with:
Background The National Audit of Dementia (NAD) care in general hospitals is commissioned by the Healthcare Quality Improvement Partnership on behalf of NHS England and the Welsh Government, as part of
More informationMEMORANDUM OF UNDERSTANDING THE INDEPENDENT FUNDRAISING STANDARDS & ADJUDICATION PANEL FOR SCOTLAND AND THE FUNDRAISING REGULATOR
MEMORANDUM OF UNDERSTANDING THE INDEPENDENT FUNDRAISING STANDARDS & ADJUDICATION PANEL FOR SCOTLAND AND THE FUNDRAISING REGULATOR This Memorandum of Understanding is not legally binding on either party.
More informationAdding Value to the NHS, Health and Care, through Research Management, Support & Leadership
Invitation to Comment This new draft strategy has been developed to ensure that the Forum continues to thrive, that we meet the needs of the community over the next five years, and that by acting together
More informationongoing development of governance and leadership to support improvement ongoing national roll out of the electronic palliative care summary (epcs)
Update to the Review of Palliative Care Services in Scotland Since the publication of Living and Dying Well a national action plan for palliative and end of life care in Scotland in October 2008 considerable
More informationReport by the Comptroller and. SesSIon January Improving Dementia Services in England an Interim Report
Report by the Comptroller and Auditor General HC 82 SesSIon 2009 2010 14 January 2010 Improving Dementia Services in England an Interim Report 4 Summary Improving Dementia Services in England an Interim
More informationDriving Improvement in Healthcare Our Strategy
Driving Improvement in Healthcare Healthcare Improvement Scotland 2014 First published April 2014 The contents of this document may be copied or reproduced for use within NHSScotland, or for educational,
More informationAn Ethics Committee in the Third Sector: Process and pitfalls
Scottish Journal of Residential Child Care 2016 Vol.15, No.1 An Ethics Committee in the Third Sector: Process and pitfalls Ruby Whitelaw and Dan Johnson Keywords Ethics, implementation, policy, evaluation,
More informationDear Colleagues, EXTENSION OF PAUSE TO THE USE OF VAGINAL MESH
29/03/2019 NHS Improvement and NHS England Wellington House 133-155 Waterloo Road London SE1 8UG 020 3747 0000 www.england.nhs.uk www.improvement.nhs.uk To: Regional Directors, Trust Medical Directors,
More informationStudy protocol. Version 1 (06 April 2011) Ethics ref: R&D ref: UK CRC portfolio ID:
Identifying and prioritising important research questions for the treatment of eczema a collaborative partnership between patients, carers, clinicians and researchers Study protocol Version 1 (06 April
More informationMembership Recruitment and Engagement Strategy
Membership Recruitment and Engagement Strategy 2015-2018 Contents 1. Introduction 2 2. Current position 2 3. Recruitment 2 4. Engagement 4 5. Strategy Review /Evaluation. 5 APPENDIX 1 Action Plan 6 1.
More informationEmergency Medicine Priority Setting Partnership. PROTOCOL (Version 1: )
Emergency Medicine Priority Setting Partnership PROTOCOL (Version 1: 22.10.2015) Purpose The purpose of this protocol is to set out the aims, objectives and commitments of the Emergency Medicine Priority
More informationLiving Evidence Network
Living Evidence Network Governance Structure Adopted July 2018 Trusted evidence. Informed decisions. Better health. Living Evidence Network: Governance Structure 2 Contents Background 3 About the Living
More informationApplication Pack. Endometriosis UK Trustees
Application Pack Endometriosis UK Trustees RECRUITING FOR THREE NEW TRUSTEES WITH A BACKGROUND IN: MARKETING AND COMMUNICATIONS CHARITY INCOME GENERATION AND FUNDRAISING HEALTH POLICY Contents 1. Welcome
More informationHEALTHWATCH AND HEALTH AND WELLBEING BOARDS
HEALTHWATCH AND HEALTH AND WELLBEING BOARDS INTRODUCTION In April 2013 local Healthwatch organisations came into being. The national body, Healthwatch England, with clear responsibilities and powers, was
More information2008 Public Status Report on the Implementation of the European Risk Management Strategy. Executive Summary
European Medicines Agency London, 17 March 2009 Doc. Ref. EMEA/43556/2009 2008 Status Report on the Implementation of the European Risk Management Strategy Executive Summary The European Risk Management
More informationScottish Medicines Consortium
Scottish Medicines Consortium Mr Fergus D Cochrane Clerk to the Public Petitions Committee Directorate of Clerking and Reporting TG.01 The Scottish Parliament Edinburgh EH99 1SP Date 4 April 2008 Enquiries
More informationKidney Transplantation
James Lind Alliance Priority Setting Partnership in Kidney Transplantation PROTOCOL Version 1.4 12 th June 2014 Purpose The purpose of this protocol is to set out the aims, objectives and commitments of
More informationNational Group for Volunteering in NHS Scotland
National Group for Volunteering in NHS Scotland Minutes of the meeting held on Tuesday 23 August 2016 at Delta House, West Nile Street, Glasgow Present Neil Galbraith Rob Coward Sandie Dickson Marion Findlay
More informationTHE CARDIFF COMMITMENT TO YOUTH ENGAGEMENT AND PROGRESSION: REPORT OF DIRECTOR OF EDUCATION & LIFELONG LEARNING
CITY OF CARDIFF COUNCIL CYNGOR DINAS CAERDYDD EXECUTIVE PUBLIC SERVICES BOARD: 10 TH MARCH 2017 THE CARDIFF COMMITMENT TO YOUTH ENGAGEMENT AND PROGRESSION: REPORT OF DIRECTOR OF EDUCATION & LIFELONG LEARNING
More informationSCREENING FOR BOWEL CANCER USING FLEXIBLE SIGMOIDOSCOPY REVIEW APPRAISAL CRITERIA FOR THE UK NATIONAL SCREENING COMMITTEE
SCREENING FOR BOWEL CANCER USING FLEXIBLE SIGMOIDOSCOPY REVIEW APPRAISAL CRITERIA FOR THE UK NATIONAL SCREENING COMMITTEE The Condition 1. The condition should be an important health problem Colorectal
More informationA PATIENT AND PUBLIC INVOLVEMENT STRATEGY RESEARCH DESIGN SERVICE NORTH WEST. November 2011 Version 2.0
A PATIENT AND PUBLIC INVOLVEMENT STRATEGY RESEARCH DESIGN SERVICE NORTH WEST November 2011 Version 2.0 Page 1 of 8 Our aim The overall aim of the NIHR Research Design Service North West (NIHR RDS NW) in
More informationDraft Accreditation Report for consultation
Guidance producer: Duchenne Muscular Dystrophy Care Considerations Working Group Guidance product: Diagnosis and Management of Duchenne Muscular Dystrophy guideline Date: 24 June 2011 Draft Accreditation
More informationPOSITION STATEMENT. Diabetic eye screening April Key points
POSITION STATEMENT Title Date Diabetic eye screening April 2013 Key points Diabetic retinopathy is the most common cause of sight loss in the working age population (1) All people with any type of diabetes
More informationProcess for End of Life and Very Rare Conditions (orphan and ultra-orphan medicines)
PACE (Patient & Clinician Engagement) Overview Document Process for End of Life and Very Rare Conditions (orphan and ultra-orphan medicines) Introduction The Scottish Medicines Consortium (SMC) has changed
More informationStrategic Plan
Strategic Plan 2015 18 President s message The Royal College of Psychiatrists is committed to improving the lives of people with mental illness. This strategic plan is based on the top three priorities
More informationNIHR Supporting collaboration in life sciences research
NIHR Supporting collaboration in life sciences research Dr Matt Hallsworth - Head of External Relations, NIHR Office for Clinical Research Infrastructure (NOCRI) Research funders build capabilities and
More informationCore Standard 24. Cass Sandmann Emergency Planning Officer. Pat Fields Executive Director for Pandemic Flu Planning
Trust Board Meeting Agenda Item 7 Date: 30 September 2009 Title of Report Recommendations (please outline the purpose of the report and the key issues for consideration/decision) Progress with Pandemic
More informationYouth Justice National Development Team. Youth Justice National Development Team Annual Report. Fiona Dyer
Youth Justice National Development Team 2012-2013 Youth Justice National Development Team Annual Report Fiona Dyer National Development Team April 2013 0 Annual Report April 2012 March 2013 Youth Justice
More informationScoping exercise to inform the development of an education strategy for Children s Hospices Across Scotland (CHAS) SUMMARY DOCUMENT
School of Health and Social Care Scoping exercise to inform the development of an education strategy for Children s Hospices Across Scotland (CHAS) SUMMARY DOCUMENT Background Children s palliative care
More informationR e s e a r c h S t r a t e g y
Sheffield Teaching Hospitals NHS Foundation Trust Academic Directorate of Specialised Cancer R e s e a r c h S t r a t e g y Academic Directorate of Specialised Cancer Research Strategy Executive Summary
More informationMemorandum of Understanding
Memorandum of Understanding This Memorandum of Understanding is made on the day of 2015 Memorandum of Understanding Between Community Housing Cymru Group 2 Ocean Way, Cardiff, CF24 5TG And Public Health
More informationGambling issues - update
Gambling issues - update Purpose of report For information. Summary This paper introduces a presentation by Leeds City Council on their recent research into problem gambling and financial inclusion, and
More informationVIOLENCE PREVENTION ALLIANCE TERMS OF REFERENCE
VIOLENCE PREVENTION ALLIANCE TERMS OF REFERENCE Background Each year, around 520,000 people die as a result of interpersonal violence, which includes child maltreatment, youth violence, intimate partner
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Diabetes dietary review Potential output: Recommendations
More informationAccess to clinical trial information and the stockpiling of Tamiflu. Department of Health
MEMORANDUM FOR THE COMMITTEE OF PUBLIC ACCOUNTS HC 125 SESSION 2013-14 21 MAY 2013 Department of Health Access to clinical trial information and the stockpiling of Tamiflu 4 Summary Access to clinical
More informationPOLICY BRIEFING National Suicide Prevention Strategies
POLICY BRIEFING National Suicide Prevention Strategies Governments and devolved administrations in all five nations across the UK and ROI have developed and published their own national suicide prevention
More informationProstate Cancer Screening Where are we? Prof. Bob Steele Professor of Surgery, University of Dundee Independent Chair, UK NSC
Prostate Cancer Screening Where are we? Prof. Bob Steele Professor of Surgery, University of Dundee Independent Chair, UK NSC 1990 Screening The detection of disease in asymptomatic people in order to
More informationAn evidence rating scale for New Zealand
Social Policy Evaluation and Research Unit An evidence rating scale for New Zealand Understanding the effectiveness of interventions in the social sector Using Evidence for Impact MARCH 2017 About Superu
More informationPrevention Concordat for Better Mental Health An Overview January Julie Daneshyar North East Public Health England Centre
Prevention Concordat for Better Mental Health An Overview January 2018 Julie Daneshyar North East Public Health England Centre Why was the Prevention Concordat set up? The programme has been set up in
More informationExecutive Summary Dr Sam Wright
Family Approach to Criminal Justice Services in Thames Valley Executive Summary Dr Sam Wright 1 The project In April 2011, Thames Valley Partnership was granted funding by the Esmée Fairbairn Foundation
More informationNational Cross Cultural Dementia Network (NCCDN) A Knowledge Network of value
National Cross Cultural Dementia Network (NCCDN) A Knowledge Network of value One in eight Australians with dementia do not speak English at home. Dementia does not discriminate; it affects all people
More informationIntegrated Cancer Services Action Plan. Colchester Hospital University NHS Foundation Trust 31 March 2014
Integrated Cancer Services Action Plan Colchester Hospital University NHS Foundation Trust 31 March KEY Implemented, clearly evidenced and externally approved On Track to deliver Some issues narrative
More informationSafeguarding Business Plan
Safeguarding Business Plan 2015-2018 Contents 1. Introduction 2. The Care Act 3. Organisational Development 4. Vision, Values and Strategic Objectives 5. Financial Plan 6. Appendix A Action Plan 7. Appendix
More informationAcademic Clinical Fellowship in Geriatric Medicine
Academic Clinical Fellowship in Geriatric Medicine Description of ACF Programme: Title: Geriatric Medicine Duration: 3 years Lead NHS Hospital/Trust and contact details: University Hospital Southampton
More informationPublic Engagement and Public and Patient Involvement. NIHR Newcastle Biomedical Research Centre and Biomedical Research Unit
Public Engagement and Public and Patient Involvement NIHR Newcastle Biomedical Research Centre and Biomedical Research Unit Our vision Patients, their carers and the wider public are a fundamental and
More informationHospital Caterers Association
Hospital Caterers Association www.hospitalcaterers.org Patron Application Pack 1 Contents What is the Hospital Caterers Association? 3 Branches of The Association 4 Why become a Patron 5 How to join 6
More informationREGIONAL SPECIALIZED GERIATRIC SERVICES GOVERNANCE AUTHORITY. Call for Expressions of Interest from Seniors Advocate/Public Member
REGIONAL SPECIALIZED GERIATRIC SERVICES GOVERNANCE AUTHORITY Call for Expressions of Interest from Seniors Advocate/Public Member A. BACKGROUND Specialized Geriatric Services (SGS) provide a range of services
More informationWorking with you to make Highland the healthy place to be
Assynt House Beechwood Park Inverness, IV2 3HG Telephone: 01463 717123 Fax: 01463 235189 Textphone users can contact us via Typetalk: Tel 0800 959598 www.show.scot.nhs.uk/nhshighland/ MINUTE of MEETING
More informationAffiliates Newsletter April 2009
MESSAGE FROM THE CHAIR Dear Colleague, Welcome to our second Affiliates Newsletter of 2009. We are currently in the process of finalising our Business Plan for our third year to March 2010 and I am delighted
More informationBMA knowledge sharing event with patient/lay groups
BMA knowledge sharing event with patient/lay groups 7 February 2017 British Medical Association bma.org.uk 1 On 7 February 2017, the BMA hosted patient/lay representatives from 11 external medical professional
More informationCABINET PROCURING A SUBSTANCE MISUSE & COMMUNITY TREATMENT SERVICE IN RUTLAND
CABINET Report No: 105/2017 PUBLIC REPORT 16 May 2017 PROCURING A SUBSTANCE MISUSE & COMMUNITY TREATMENT SERVICE IN RUTLAND Report of the Director of Public Health Strategic Aim: Safeguarding Key Decision:
More information